Berberine

目录号: GN10221纯度: >99.50%同义词: 黄连素; Natural Yellow 18

小檗碱(Natural Yellow 18)是一种从中草药黄连中分离出来的生物碱,作为一种抗生素。


Berberine
Cas No.: 2086-83-1
规格价格库存数量操作
20mg¥357.00现货
1
10mM (in 1mL DMSO)¥389.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Berberine (Natural Yellow 18) is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine (Natural Yellow 18) induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Berberine (Natural Yellow 18) has antineoplastic properties[1].

Berberine (1.25-160 μM; 72 hours) has potential inhibitory effects on the proliferation of four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29[1]. Berberine (1.25-160 μM; 24-72 hours) induces a time- and dose-dependent inhibition of LoVo cell growth[1]. LoVo cells are exposure to Berberine (10-80 μM) for 24 h. Cell cycle analysis of 40 μM Berberine-treated LoVo cells by flow cytometry shows accumulation of cells in the G2/M phase[1].Berberine (10-80 μM) suppresses cyclin B1, cdc2 and cdc25c protein expression after 24 h, especially at the dose of 80.0 μM[1].

Berberine (10, 30, or 50 mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine at doses of 30 and 50 mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice[1].

黄连素(天然黄18)是从中国草药黄连中分离出的一种生物碱,具有抗生素的作用。黄连素能够诱导产生活性氧自由基(ROS),并抑制DNA拓扑异构酶。黄连素具有抗肿瘤的特性[1]。

黄连素(1.25-160 μM;72小时)对四种结肠癌细胞系LoVo、HCT116、SW480和HT-29的增殖具有潜在的抑制作用[1]。黄连素(1.25-160 μM;24-72小时)呈现出对LoVo细胞生长的时间和剂量依赖性抑制作用[1]。将LoVo细胞暴露于10-80 μM浓度的黄连素中处理24小时后,通过流式细胞术分析显示,40 μM浓度的黄连素可导致细胞在G2/M期的积累[1]。黄连素(10-80 μM)可在24小时后抑制cyclin B1、cdc2和cdc25c蛋白表达,尤其在80.0 μM的浓度下表现更为显著[1]。

黄连素(10、30或50 mg/kg/天;经胃灌注;连续10天)能够抑制人类结肠腺癌在体内的生长。黄连素以30和50 mg/kg/天的剂量经胃灌注可分别对裸鼠人类结肠腺癌异种移植物的生长呈现出33.1%和45.3%的抑制率[1]

References:
[1]. Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68(1):53-62.

实验参考方法 Experimental Reference Method

Cell experiment [1]:

Cell lines

human hepatoma cell lines (HepG2 cells)

Preparation method

General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

0.5, 2.5, 5, 7.5, 10, 15 μg/ml, 24 h

Applications

Berberine as a new upregulator of liver LDLR (low-density lipoprotein receptor) expression. In HepG2 cells, the effect of berberine was also dose dependent. Northern blot showed a 50% increase in LDLR mRNA in cells treated with 2.5 μg/ml of berberine and a maximal increase of four fold of control was seen with a concentration of 15 μg/ml. The effect of BBR on LDLR was further confirmed in another human hepatoma cell line, Bel-7402. BBR at 2.5 μg/ml increased the LDLR mRNA in these cells by 2.3-fold.

Animal experiment [2]:

Animal models

female golden hamsters

Dosage form

orally twice a day at 50 mg/kg/d or 100 mg/kg/d for 10 d.

Application

In hamsters, treatment of these hyperlipidemic animals with berberine by oral administration for 10 d resulted in dose-dependent decreases in both serum total cholesterol and LDL-c. After the 10-d treatment, berberine at a dose of 50 mg/kg/d reduced LDL-c by 26%, and at a dose of 100 mg/kg/d, reduced LDL-c by 42% as compared to the control animals on the same HFHC (high-fat and high-cholesterol) diet. The berberine effect was also time dependent. LDLR mRNA and protein levels were elevated in all berberine -treated hamsters in a dose-dependent manner. A 3.5-fold increase in mRNA and a 2.6-fold increase in protein in hamster livers treated with 100 mg/kg/d of berberine were detected.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Kong, W.,Wei, J.,Abidi, P., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine 10(12), 1344-1351 (2004).

产品文档 Product Documents

Purity:>99.50%

化学性质Chemical Properties

CAS 号
2086-83-1
同义词
黄连素; Natural Yellow 18
化学名
9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium
SMILES
[H]C(C([H])([H])C1=C2[H])([H])[N+](C([H])=C(C(OC([H])([H])[H])=C3OC([H])([H])[H])C(C([H])=C3[H])=C4[H])=C4C1=C([H])C5=C2OC([H])([H])O5
分子式
C20H18NO4
分子量
336.36 g/mol
溶解性
≥ 14.95mg/mL in DMSO
保存条件
Store at -20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol